Citations per year, relative to R Fauvert R Fauvert (= 1×)
peers
Summerskill Wh
Countries citing papers authored by R Fauvert
Since
Specialization
Citations
This map shows the geographic impact of R Fauvert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Fauvert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Fauvert more than expected).
This network shows the impact of papers produced by R Fauvert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Fauvert. The network helps show where R Fauvert may publish in the future.
Co-authorship network of co-authors of R Fauvert
This figure shows the co-authorship network connecting the top 25 collaborators of R Fauvert.
A scholar is included among the top collaborators of R Fauvert based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with R Fauvert. R Fauvert is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Fauvert, R, et al.. (2000). [Myxedema with goiter caused by a disorder in the thyroidal synthesis of hormone appearing at a late stage in an adult].. PubMed. 19(2). 343–55.
2.
Boivin, Pierre, et al.. (1998). [True primary erythroblastopenia in the adult].. PubMed. 2. 760–8.
3.
Ménaché, D, et al.. (1971). [Hemostasis disorders during severe viral hepatitis: clinical, anatomical and biological study].. PubMed. 122(5). 605–12.5 indexed citations
Feldmann, Gérard, et al.. (1968). [Hepatic ultrastructure during Gilbert's disease].. PubMed. 16(21). 943–53.4 indexed citations
6.
Fauvert, R, et al.. (1967). [Hepatic ultrastructure. II. The pathological liver].. PubMed. 12(7). 641–65.2 indexed citations
7.
Erlinger, Serge, et al.. (1966). Effets de la novobiocine sur le fonctionnement du foie. II. Etude expérimentale.. 11(7).2 indexed citations
8.
Jp, Benhamou, et al.. (1966). [Cardiac output during liver diseases. Effects of portacaval anastomosis and diuretics].. PubMed. 16(4). 955–83.5 indexed citations
9.
Berthelot, P., et al.. (1965). [DRUG-INDUCED HEPATITIS. II. ANALYTIC STUDY OF RESPONSIBLE DRUGS].. PubMed. 10. 140–79.2 indexed citations
10.
Erlinger, Serge, et al.. (1965). [THE SERUM ALKALINE PHOSPHATASE IN LIVER DISEASES].. PubMed. 73. 1–6.2 indexed citations
11.
Meyer, Paul N., et al.. (1963). [ATTEMPTED CLASSIFICATION OF CYSTIC LESIONS OF THE KIDNEY AS A FUNCTION OF ASSOCIATED HEPATIC LESIONS].. PubMed. 69. 617–22.1 indexed citations
12.
Fauvert, R, et al.. (1963). [Cholestatic hepatitis due to carbutamide].. PubMed. 71. 1287–90.3 indexed citations
Jp, Benhamou & R Fauvert. (1958). [Primary cancer of the liver in France; 25 cases].. PubMed. 34(3/1). 121–34SP.1 indexed citations
15.
Fauvert, R, et al.. (1958). [Clinical studies on hepatic clearances].. PubMed. 8(7). 525–47.1 indexed citations
16.
Burtin, P, L Hartmann, J.F. Heremans, et al.. (1957). [Immunochemical and immunoelectrophoretic studies in macroglobulinemia].. PubMed. 2(2). 161–77.8 indexed citations
17.
Burtin, P, R Fauvert, P Grabar, & L Hartmann. (1956). [Immuno-electrophoretic analysis of the sera of patients with liver diseases].. PubMed. 243(23). 1937–9.6 indexed citations
18.
Jp, Benhamou, L Hartmann, & R Fauvert. (1955). Transient hepatic coma. II. Biological and therapeutic study.. PubMed. 63(73). 1495–7.1 indexed citations
19.
Benhamou, J P, L Hartmann, & R Fauvert. (1955). Transient hepatic coma. I. Clinical study.. PubMed. 63(71). 1451–4.4 indexed citations
20.
Alagille, D, L Hartmann, & R Fauvert. (1953). [Analytical study of Quick test in hepatic insufficiency by differential determination of prothrombin, proconvertin and proaccelerin].. PubMed. 29(66). 3375–86.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.